D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 116 Citations 120,934 629 World Ranking 1877 National Ranking 57

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Heart failure
  • Cardiology

His main research concerns Heart failure, Internal medicine, Cardiology, Ejection fraction and Myocardial infarction. His Heart failure research is multidisciplinary, relying on both Renal function, Blood pressure, Intensive care medicine, Placebo and Kidney. His work investigates the relationship between Internal medicine and topics such as Endocrinology that intersect with problems in Urology and Gastroenterology.

His research in Cardiology intersects with topics in Clinical endpoint and Erythropoietin. His Ejection fraction research also works with subjects such as

  • COPD which intersects with area such as Diabetes mellitus,
  • Proportional hazards model that intertwine with fields like Heart rate. His work in Myocardial infarction covers topics such as Coronary artery disease which are related to areas like Acute coronary syndrome and Cardiac function curve.

His most cited work include:

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. (9345 citations)
  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (6276 citations)
  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. (5331 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Heart failure, Cardiology, Ejection fraction and Renal function. His Hazard ratio, Myocardial infarction and Heart failure with preserved ejection fraction study in the realm of Internal medicine interacts with subjects such as In patient. In Heart failure, Adriaan A. Voors works on issues like Intensive care medicine, which are connected to Rolofylline.

His Cardiology study combines topics in areas such as Serelaxin, Surgery and Diastole. His Ejection fraction research incorporates elements of Biomarker and Diabetes mellitus. His work carried out in the field of Renal function brings together such families of science as Creatinine, Kidney, Kidney disease and Urology.

He most often published in these fields:

  • Internal medicine (84.13%)
  • Heart failure (78.14%)
  • Cardiology (63.86%)

What were the highlights of his more recent work (between 2017-2021)?

  • Heart failure (78.14%)
  • Internal medicine (84.13%)
  • Cardiology (63.86%)

In recent papers he was focusing on the following fields of study:

Heart failure, Internal medicine, Cardiology, Ejection fraction and Hazard ratio are his primary areas of study. His Heart failure research incorporates themes from Clinical trial, Renal function, Placebo, Atrial fibrillation and Biomarker. Adriaan A. Voors undertakes multidisciplinary investigations into Internal medicine and In patient in his work.

His studies in Cardiology integrate themes in fields like Proportional hazards model and Blood pressure. His biological study spans a wide range of topics, including Cohort study, Diabetes mellitus, Coronary artery disease, Beta blocker and Heart rate. His study looks at the relationship between Hazard ratio and fields such as Gastroenterology, as well as how they intersect with chemical problems.

Between 2017 and 2021, his most popular works were:

  • Angiotensin?converting enzyme 2 (ACE2), SARS?CoV?2 and the pathophysiology of coronavirus disease 2019 (COVID?19) (228 citations)
  • How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (221 citations)
  • Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology (218 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Heart failure
  • Cardiology

Adriaan A. Voors mainly focuses on Heart failure, Internal medicine, Cardiology, Ejection fraction and Hazard ratio. In general Heart failure study, his work on Acute decompensated heart failure often relates to the realm of In patient, thereby connecting several areas of interest. His study in Heart failure with preserved ejection fraction, Clinical trial, Confidence interval, Renal function and Randomized controlled trial falls under the purview of Internal medicine.

Adriaan A. Voors works mostly in the field of Cardiology, limiting it down to concerns involving Adrenomedullin and, occasionally, Severity of illness, Lung ultrasound and Pulmonary congestion. His studies deal with areas such as Interquartile range, Cohort study, Renin–angiotensin system, Mineralocorticoid receptor and Electrocardiography as well as Ejection fraction. His research integrates issues of Gastroenterology, Mortality rate, Body mass index and Volume overload in his study of Hazard ratio.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno.
European Journal of Heart Failure (2016)

19435 Citations

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Piotr Ponikowski;Adriaan A Voors;Stefan D Anker;Héctor Bueno.
European Heart Journal (2016)

11742 Citations

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Stamatis Adamopoulos;Stefan D. Anker;Volkmar Falk;Lars Køber.
European Heart Journal (2012)

10477 Citations

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof;Stefano Benussi;Dipak Kotecha;Anders Ahlsson.
Europace (2016)

8635 Citations

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio.
European Heart Journal (2012)

7218 Citations

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial

Scott D. Solomon;Michael R. Zile;Burkert Pieske;Adriaan A Voors.
The Lancet (2012)

1086 Citations

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

John R Teerlink;Gad Cotter;Beth A Davison;G Michael Felker.
The Lancet (2013)

909 Citations

Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease

Kevin Damman;Vincent M. van Deursen;Gerjan Navis;Adriaan A. Voors.
Journal of the American College of Cardiology (2009)

765 Citations

EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

Aldo P. Maggioni;Ulf Dahlstrom;Gerasimos Filippatos;Ovidiu Chioncel.
European Journal of Heart Failure (2013)

756 Citations

Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.

Kevin Damman;Mattia A. E. Valente;Adriaan A. Voors;Christopher M. O'Connor.
European Heart Journal (2014)

675 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Adriaan A. Voors

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 482

John J.V. McMurray

John J.V. McMurray

University of Glasgow

Publications: 310

John G.F. Cleland

John G.F. Cleland

National Institutes of Health

Publications: 249

Alexandre Mebazaa

Alexandre Mebazaa

Université Paris Cité

Publications: 244

Marco Metra

Marco Metra

University of Brescia

Publications: 240

Javed Butler

Javed Butler

University of Mississippi

Publications: 235

Scott D. Solomon

Scott D. Solomon

Brigham and Women's Hospital

Publications: 229

Gerasimos Filippatos

Gerasimos Filippatos

National and Kapodistrian University of Athens

Publications: 221

Faiez Zannad

Faiez Zannad

University of Lorraine

Publications: 213

Dirk J. van Veldhuisen

Dirk J. van Veldhuisen

University Medical Center Groningen

Publications: 209

Antoni Bayes-Genis

Antoni Bayes-Genis

Autonomous University of Barcelona

Publications: 198

Rudolf A. de Boer

Rudolf A. de Boer

University Medical Center Groningen

Publications: 187

Piotr Ponikowski

Piotr Ponikowski

Wrocław Medical University

Publications: 185

Carolyn S.P. Lam

Carolyn S.P. Lam

National University of Singapore

Publications: 178

Aldo P. Maggioni

Aldo P. Maggioni

Heart Care Foundation, ANMCO Research Center, Florence

Publications: 175

Gregg C. Fonarow

Gregg C. Fonarow

University of California, Los Angeles

Publications: 162

Trending Scientists

Xinyong Li

Xinyong Li

Dalian University of Technology

Mark E. Westgate

Mark E. Westgate

Iowa State University

Eric E. Bouhassira

Eric E. Bouhassira

Albert Einstein College of Medicine

Stephen L. Brusatte

Stephen L. Brusatte

University of Edinburgh

Marcel J. F. Stive

Marcel J. F. Stive

Delft University of Technology

Eric Buffetaut

Eric Buffetaut

École Normale Supérieure

Bryn Hubbard

Bryn Hubbard

Aberystwyth University

Zoran Nesic

Zoran Nesic

University of British Columbia

Theodore A. Fritz

Theodore A. Fritz

Boston University

Derek Evan Nee

Derek Evan Nee

Florida State University

Mary Hegarty

Mary Hegarty

University of California, Santa Barbara

Torbjörn Tomson

Torbjörn Tomson

Karolinska Institute

Gilles Paradis

Gilles Paradis

McGill University

James M. Perrin

James M. Perrin

Harvard University

M. Gail Jones

M. Gail Jones

North Carolina State University

Richard Sakwa

Richard Sakwa

University of Kent

Something went wrong. Please try again later.